| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/22/2015 | US20150025133 Nutritional compositions including rrr-alpha tocopherol and polyunsaturated fatty acids |
| 01/22/2015 | US20150025131 PATULETIN A POTENT ANTI-TNF-a AND ANTI-ARTHRITIC COMPOUND FROM TAGETES PATULA |
| 01/22/2015 | US20150025130 Sterol derivative, preparation method therefor and use thereof |
| 01/22/2015 | US20150025129 Compounds, compositions, pharmaceutical compositions, and methods of use |
| 01/22/2015 | US20150025126 Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network |
| 01/22/2015 | US20150025123 P2X7, Inhibition Of Epithelial Cancers And Papillomas |
| 01/22/2015 | US20150025122 Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro |
| 01/22/2015 | US20150025121 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
| 01/22/2015 | US20150025119 Release Application for Antihypertensive Agent on Plant Fiber Bundle |
| 01/22/2015 | US20150025115 Benzimidazole compound crystal |
| 01/22/2015 | US20150025112 Orally disintegrating tablet formulations of donepezil |
| 01/22/2015 | US20150025109 Method for the Treatment of Neurological Disorders by Enhancing the Activity of Beta-Glucocerebrosidase |
| 01/22/2015 | US20150025108 8-hydroxy quinoline derivatives |
| 01/22/2015 | US20150025107 Pharmaceutical compositions for combination therapy |
| 01/22/2015 | US20150025106 Thermogel formulation for combination drug delivery |
| 01/22/2015 | US20150025104 Nutraceuticals Having Sustained Release for Improved Bioavailability and Method of Production |
| 01/22/2015 | US20150025103 Oral liquid concentrate comprising brompheniramine, pseudoephedrine and dextromethorphan |
| 01/22/2015 | US20150025102 Buprenorphine-Wafer for Drug Substitution Therapy |
| 01/22/2015 | US20150025101 Opioid agonist/antagonist combinations |
| 01/22/2015 | US20150025100 Formulations for parenteral delivery of compounds and uses thereof |
| 01/22/2015 | US20150025096 Small molecule compounds to treat hearing loss |
| 01/22/2015 | US20150025095 Diaminopyrimidines And Uses Thereof |
| 01/22/2015 | US20150025090 Substituted azabicycles and use thereof |
| 01/22/2015 | US20150025086 Treatment of circadian rhythm disorders |
| 01/22/2015 | US20150025084 High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient |
| 01/22/2015 | US20150025083 Procaspase combination therapy for glioblastoma |
| 01/22/2015 | US20150025082 Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
| 01/22/2015 | US20150025081 Novel phenylimidazole derivatives as pde10a enzyme inhibitors |
| 01/22/2015 | US20150025076 Modulators of atp-binding cassette transporters |
| 01/22/2015 | US20150025074 Methods and compositions for treating solid tumors and other malignancies |
| 01/22/2015 | US20150025072 Quinazolinone compounds |
| 01/22/2015 | US20150025071 Tetrahydro-quinazolinone derivatives as tank and parp inhibitors |
| 01/22/2015 | US20150025066 Cyclic diaminopyrimidine derivatives |
| 01/22/2015 | US20150025065 New azabenzimidazole derivatives |
| 01/22/2015 | US20150025064 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof |
| 01/22/2015 | US20150025063 Antiparkinsonian Action of Phenylisopropylamines |
| 01/22/2015 | US20150025062 Hcn inhibitors affecting ganglion cell function and visual function |
| 01/22/2015 | US20150025061 Gabaa receptor antagonists affecting ganglion cell function and visual acuity |
| 01/22/2015 | US20150025060 Foamable Compositions and Kits Comprising One or More of a Channel Agent, a Cholinergic Agent, A nitric Oxide Donor and Related Agents and Their Uses |
| 01/22/2015 | US20150025058 8 - substituted 2 -amino - [1,2,4] triazolo [1, 5 -a] pyrazines as syk tryrosine kinase inhibitors and gcn2 serin kinase inhibitors |
| 01/22/2015 | US20150025057 Triazine-oxadiazoles |
| 01/22/2015 | US20150025056 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 01/22/2015 | US20150025052 Compositions and Methods for Inhibiting HSP90/HSP70 Machinery |
| 01/22/2015 | US20150025051 Formulations for treating skin disorders |
| 01/22/2015 | US20150025050 Corticosteroids for the Treatment of Joint Pain |
| 01/22/2015 | US20150025049 Compositions comprising exemestane and novel methods of use |
| 01/22/2015 | US20150025048 Methods for enhancing, improving, or increasing fertility or reproductive function |
| 01/22/2015 | US20150025047 Nutritional Intervention for Improving Muscular Function and Strength |
| 01/22/2015 | US20150025046 Preparation and use of bicyclic himbacine derivatives as par-1 receptor antagonists |
| 01/22/2015 | US20150025045 CBP AND p300-MEDIATED TRANSCRIPTION MODULATORS AND RELATED METHODS |
| 01/22/2015 | US20150025043 Oral formulations of mitochondrially-targeted antioxidants and their preparation and use |
| 01/22/2015 | US20150025042 Compounds For Treating Proliferative Disorders |
| 01/22/2015 | US20150025041 Antiviral therapies with phospholipase d inhibitors |
| 01/22/2015 | US20150025039 Antiviral phosphonate analogs |
| 01/22/2015 | US20150025033 Composition for the management of nausea and vomiting |
| 01/22/2015 | US20150025032 Composition for the management of nausea and vomiting |
| 01/22/2015 | US20150025031 Metabolic downregulation for cell survival |
| 01/22/2015 | US20150025029 Aptamer bioconjugate drug delivery device |
| 01/22/2015 | US20150025028 Method for Treating Abnormal Polyglutamine-Mediated Disease |
| 01/22/2015 | US20150025027 Combination of a Monosubstituted Sulfamate Derivate of the Natural Monosaccharide d-Fructose (Topiramate) with an Anti-Depressant from the Phenyl Ketone Class (Bupropion) for Treating Obesity and Plurimetabolic Syndromes |
| 01/22/2015 | US20150025026 Reduction of gastrointestinal tract colonisation by campylobacter |
| 01/22/2015 | US20150025025 Immuno-modulators for treating functional epithelial syndromes |
| 01/22/2015 | US20150025024 Solid Compositions |
| 01/22/2015 | US20150025023 Cyclodextrin |
| 01/22/2015 | US20150025020 Self-preserved oil dispersions comprising boric acid |
| 01/22/2015 | US20150025019 Method for Dosage Adjustment of Drugs that Prevent Elastic Fiber Breakdown |
| 01/22/2015 | US20150025015 Keratin compositions comprising halofuginone |
| 01/22/2015 | US20150025012 Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling |
| 01/22/2015 | US20150025008 Compositions and Methods of Detecting and Treating Neural Tube Defects |
| 01/22/2015 | US20150025006 Pharmaceutical Combinations Including Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders |
| 01/22/2015 | US20150025000 Methods for Treating HCV |
| 01/22/2015 | US20150024999 Methods for Treating HCV |
| 01/22/2015 | US20150024996 Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| 01/22/2015 | US20150024995 Combination Of Dopamine Agonists Plus First Phase Insulin Secretagogues For The Treatment Of Metabolic Disorders |
| 01/22/2015 | US20150024074 Methods for treating skin barrier and reducing acne |
| 01/22/2015 | US20150024071 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 01/22/2015 | US20150024070 Ingestible canker sore treatment |
| 01/22/2015 | US20150024069 Compositions and methods for treatment of hemorrhage |
| 01/22/2015 | US20150024068 Dialysis composition comprising citrate, calcium and magnesium |
| 01/22/2015 | US20150024067 Ingestible canker sore treatment |
| 01/22/2015 | US20150024065 Treatment of retroviral reservoirs exploiting oxidative stress |
| 01/22/2015 | US20150024064 pKa Buffered Vitamin C Composition and Method |
| 01/22/2015 | US20150024061 Alloplastic injectable dermal filler and methods of use thereof |
| 01/22/2015 | US20150024060 Nutraceuticals Having Sustained Release for Improved Bioavailability and Method of Production |
| 01/22/2015 | US20150024059 Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes |
| 01/22/2015 | US20150024058 Pharmaceutical Compositions for the Deterrence and/or Prevention of Abuse |
| 01/22/2015 | US20150024057 Non-digestible sugar-coated products and process |
| 01/22/2015 | US20150024056 Controlled release sterile injectable aripiprazole formulation and method |
| 01/22/2015 | US20150024055 Enhanced immediate release formulations of topiramate |
| 01/22/2015 | US20150024054 Solid pharmaceutical dispersions with enhanced bioavailability |
| 01/22/2015 | US20150024053 Topical wound treatment method and composition |
| 01/22/2015 | US20150024049 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 01/22/2015 | US20150024048 Controlled release pharmaceutical compositions for prolonged effect |
| 01/22/2015 | US20150024047 Pharmaceutical composition and administrations thereof |
| 01/22/2015 | US20150024046 Abuse-proofed oral dosage form |
| 01/22/2015 | US20150024045 Liquid-filled hard gel capsule pharmaceutical formulations |
| 01/22/2015 | US20150024042 Phased dosing of clopidogrel |
| 01/22/2015 | US20150024041 Health Supplement using Guarana Extract |
| 01/22/2015 | US20150024040 Administration regime for n-hydroxy-4-benzamide |
| 01/22/2015 | US20150024035 Method and system for synthesizing nanocarrier based long acting drug delivery system for methadone |